Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of AZD1222 and Sputnik Light Heterologous Boost for COVID-19
NCT04686773Phase 2Completed
- Sponsor
- R-Pharm
- Start
- Mar 2021
- Primary completion
- Oct 2021
- Modality
- Viral Vector Vaccines, Viral Vectors
- Countries
- 1
01
Overview
A Phase 2 trial of ChAdOx1 nCoV-19, rAd26 in coronavirus disease 2019 (COVID-19), sponsored by R-Pharm. Started Mar 2021; status: completed.
02
Drugs
ChAdOx1 nCoV-19rAd26
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04686773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04686773.